IQVIA, Veeva Forge Long-Term Clinical and Commercial Partnerships

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the pair’s long-term agreement, customers can use software, data, technology, and service offerings from Veeva and IQVIA together in a simple and efficient way.

“We are committed to supporting frictionless product and services integration with IQVIA for the benefit of our joint customers and the industry overall,” Veeva Founder/CEO Peter Gassner said. “I am excited about the potential for our clinical and commercial partnerships to create significant value for our shared customers.”

The global partnerships make it easy for customers to work with IQVIA and Veeva in key areas including:

• Commercial: The companies have established master data and software third-party access (TPA) agreements that allow IQVIA or Veeva data to be used with each other’s software or services in customer instances, including the use of IQVIA data in Veeva Network for master data management (MDM), Veeva Nitro for analytics, and Veeva AI. In addition to using Veeva data in IQVIA’s commercial products and services, IQVIA has also joined the Veeva Technology, AI, and Services Partner Programs to support customer integrations between Veeva software and IQVIA Analytics, IQVIA Information Management (including MDM), IQVIA Agentic AI, and IQVIA Commercial Orchestration offerings. With these partnerships and overall master agreements in place, customers also benefit from a fast, easy process to get TPAs for projects.
• Clinical: IQVIA has joined Veeva’s CRO Clinical Data Partner program and can leverage the Veeva Clinical Suite to execute clinical trials using Veeva software products, including study builds with Veeva EDC. With this partnership, customers will benefit from IQVIA’s clinical data management, clinical technology solutions, and EDC programming expertise with Veeva software to accelerate database builds, study locks, and data delivery. 

“IQVIA and Veeva’s partnerships bring together best-in-class capabilities in information, AI, technology, and services for our shared clients,” IQVIA Chairman/CEO Ari Bousbib stated. “This will enable IQVIA customers on Veeva platforms to accelerate clinical development, bring treatments to market more efficiently, and improve access to innovations for patients.”

IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using artificial intelligence responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance, and patient safety, and delivering AI to the high standards of trust, scalability, and precision demanded by the industry. With approximately 89,000 employees in more than 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of medical treatments to help improve patient outcomes and population health worldwide.

IQVIA protects individual patient privacy. The company uses various privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures.

Veeva is a global developer/provider of cloud software for the life sciences industry. The company serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs.